MetLife Investment Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $408K | Buy |
|
|||||
|
2025
Q2 | $275K | Sell |
|
|||||
|
2025
Q1 | $228K | Sell |
|
|||||
|
2024
Q4 | $336K | Buy |
|
|||||
|
2024
Q3 | $370K | Hold |
|
|||||
|
2024
Q2 | $255K | Buy |
|
|||||
|
2024
Q1 | $285K | Hold |
|
|||||
|
2023
Q4 | $191K | Hold |
|
|||||
|
2023
Q3 | $125K | Hold |
|
|||||
|
2023
Q2 | $161K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $166K | Hold |
|
|||||
|
2021
Q3 | $237K | Buy |
|
|||||
|
2021
Q2 | $167K | Hold |
|
|||||
|
2021
Q1 | $232K | Hold |
|
|||||
|
2020
Q4 | $320K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $156K | Buy |
|